Juan Tiraboschi

15PUBLICATIONS
75CO-AUTHORS
PharmacogenomicsInnate immunityGender, sexuality and educationHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 07, 2026
Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL).

|May 04, 2026
Humoral Immunogenicity of SARS-CoV-2 mRNA Primary Vaccination Among People with HIV.

|Mar 28, 2026
Knowledge, Attitudes, and Stigma Towards People Living with HIV: An Explanatory Sequential Mixed-Methods Study Among 1013 Healthcare Professionals in Spain.

Yelson Alejandro Picón-Jaimes, Ivan David Lozada-Martínez, Sulaiman Kalokoh

|Feb 13, 2026
Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trials.

Priscilla Y Hsue, Laura Waters, Chloe Orkin

|Oct 23, 2025
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

Luis Buzón-Martín, Maria Luisa Montes, Roberto Pedrero

|Oct 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi

Pageof 3

Frequent Collaborators

3 joint publications

Miguel Torralba

3 joint publications

Pere Domingo

3 joint publications

Esteban Martinez

2 joint publications

Maria Saumoy